Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder which leads to mental deterioration due to aberrant accretion of misfolded proteins in the brain. According to mitochondrial cascade hypothesis, mitochondrial dysfunction is majorly involved in the pathogenesis of AD. Many drugs targeting mitochondria to treat and prevent AD are in different phases of clinical trials for the evaluation of safety and efficacy as mitochondria are involved in various cellular and neuronal functions. Mitochondrial dynamics is regulated by fission and fusion processes mediated by dynamin-related protein (Drp1). Inner membrane fusion takes place by OPA1 and outer membrane fusion is facilitated by mitofusin1 and mitofusin2 (Mfn1/2). Excessive calcium release also impairs mitochondrial functions; to overcome this, calcium channel blockers like nilvadipine are used. Another process acting as a regulator of mitochondrial function is mitophagy which is involved in the removal of damaged and non-functional mitochondria however this process is also altered in AD due to mutations in Presenilin1 (PS1) and Amyloid Precursor Protein (APP) gene. Mitochondrial dynamics is altered in AD which led to the discovery of various fission protein (like Drp1) inhibitors and drugs that promote fusion. Modulations in AMPK, SIRT1 and Akt pathways can also come out to be better therapeutic strategies as these pathways regulate functions of mitochondria. Oxidative phosphorylation is major generator of Reactive Oxygen Species (ROS) leading to mitochondrial damage; therefore reduction in production of ROS by using antioxidants like MitoQ, Curcumin and Vitamin Eis quiteeffective.
Similar content being viewed by others
Data Availability
Not applicable.
References
Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204–1222
Fawzi AA, Weintraub S, Fawzi W (2020) Retinal imaging in Alzheimer’s disease. In search of the holy grail. Ophthalmology 127:119–121
Bekris LM, Yu C-E, Bird TD, Tsuang DW (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23:213–227
Castellani RJ, Rolston K, Smith MA (2010) Alzheimer disease. Disease-a-month: DM 56:484
Hindupur K, Anandatheerthavarada BG et al (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer’s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41–54
Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E (2017) The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun 482:426–431
Flannery PJ, Trushina E (2019) Mitochondrial dysfunction in Alzheimer’s disease and progress in mitochondria-targeted therapeutics. Curr Behav Neurosci Rep 6:88–102
Longo DL, Archer SL (2013) Mitochondrial dynamics-mitochondrial fission and fusion in human diseases. N Engl J Med 369:2236–2251
Youle RJ, Van Der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337:1062–1065
Ramos ES, Motori E, Brüser C, Kühl I, Yeroslaviz A, Ruzzenente B, et al (2019) Mitochondrial fusion is required for regulation of mitochondrial DNA replication. PLoS Genet 15: e1008085
Sheng ZHQC (2012) Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13:77–93
Kerr JS, Adriaanse BA, Greig NH et al (2017) Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci 40:151–166
Carolina CC, Diego R, Moran J (2018) ROS as regulators of mitochondrial dynamics in neurons. Cellular and Mol Neurobiol 38:995–1007
Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24:R453
Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y (2004) In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15:1101–1111
Bordi M, Berg MJ, Mohan PS, Peterhoff CM, Alldred MJ, Che S et al (2016) Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy 12:2467–2483
Reddy PH, Yin XL, Manczak M, Kumar S, Pradeepkiran JA, Vijayan M et al (2018) Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease. Hum Mol Genet 27:2502–2516
Cai Q, Jeong YY (2020) Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases. Cells 9:150
Hemono M, Ubrig É, Azeredo K, Salinas-Giegé T, Drouard L, Duchêne A-M (2020) Arabidopsis voltage-dependent anion channels (VDACs): overlapping and specific functions in mitochondria. Cells 9:1023
Shoshan-Barmatz V (2020) Novel piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting vdac oligomerization, apoptosis and mitochondria dysfunction. Google Patents 2020.
Robinson A, Grösgen S, Mett J, Zimmer VC, Haupenthal VJ, Hundsdörfer B et al (2014) Upregulation of PGC-1α expression by Alzheimer’s disease-associated pathway: Presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP. Aging Cell 13:263–272
Shen Y, Wu Q, Shi J, et al (2020) Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease. Biomed and Pharmacother 132:110928
Wu J, Zeng Z, Zhang W et al (2019) Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases. Free Radical Res 53:139–149
Ban T, Kohno H, Ishihara T, Ishihara N (2018) Relationship between OPA1 and cardiolipin in mitochondrial inner-membrane fusion. Biochim Biophys Acta - Bioenerg 1859:951–957
Song Z, Ghochani M, McCaffery JM et al (2009) Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 20:3525–3532
Gui C, Ren Y, Chen J, et al (2020) p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson’s disease. Toxicol Appl Pharmacol 388:114874
Losó n OC, Song Z, Chen H, Chan DC, (2013) Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell 24:659–667
Chen H, Chan DC (2010) Physiological functions of mitochondrial fusion. Ann N Y Acad Sci 1201:21–25
Kang I, Chu CT, Kaufman BA (2018) The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS Lett 592:793–811
Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797:113–128
Zhao M et al (2021) Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics 11:1845
Paupe V, Prudent J (2018) New insights into the role of mitochondrial calcium homeostasis in cell migration. Biochem Biophys Res Commun 500:75–86
Calvo-Rodriguez M, Bacskai BJ (2021) Mitochondria and calcium in Alzheimer’s disease: from cell signaling to neuronal cell death. Trends Neurosci 44:136–151
Prole DL, Taylor CW (2019) Structure and function of ip3 receptors. Cold Spring Harb Perspect Biol 11:a035063
Marchi S, Patergnani S, Missiroli S et al (2018) Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium 69:62–72
Gaidin SG, Zinchenko VP, Teplov IY, Tuleukhanov ST, Kosenkov AM (2019) Epileptiform activity promotes decreasing of Ca2+ conductivity of NMDARs, AMPARs, KARs, and voltage-gated calcium channels in Mg2+-free model. Epilepsy Res 158:106224
Krieger C (2002) Mitochondria, Ca2+ and neurodegenerative disease. Eur J Pharmacol 447:177–188
Gunter T, Buntinas L, Sparagna G et al (2000) Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 28:285–296
Ord C, Jack R, Knopman DS, Jagust WJ, Petersen RC, Weiner MW et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. The Lancet Neurol 12:207–216
Maruszak ACŻ (2011) Mitochondrial dysfunction and Alzheimer’s disease. Prog Neuro-Psychopharmacology Biol Psychiatry 35:320–330
Mancuso M, Coppedè F, Murri L, Siciliano G (2007) Mitochondrial cascade hypothesis of Alzheimer’s disease: Myth or reality? Antioxidants Redox Signal 9:1631–1646
Swerdlow R, Burns JMSK-B, BA, (2014) U (2014) The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta - Mol Basis Dis 1842:1219–1231
Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J Neurochem 93:953–962
Fišar Z, Hansíková H, Křížová J, Jirák R, Kitzlerová E, Zvěřová M et al (2019) Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer’s disease and depressive disorder. Mitochondrion 48:67–77
Adav SS, Park JE, Sze SK (2019) Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease. Mol Brain 12:1–12
Trimmer PA et al (2000) Abnormal Mitochondrial Morphology in Sporadic Parkinson’s and Alzheimer’s Disease Cybrid Cell Lines. Exp Neurol 162:37–50
Weidling I, Swerdlow RH (2020) Mitochondria in Alzheimer’s disease and their potential role in Alzheimer’s proteostasis. Exp. Neurol 330:113321
Onyango I, Dennis J (2016) Mitochondrial dysfunction in Alzheimer’s disease and the rationale for bioenergetics based therapies. Aging Dis 7:201–214
Ułamek-Kozioł M, Czuczwar SJ, Kocki J, Januszewski S, Bogucki J, Bogucka-Kocka A et al (2019) Dysregulation of autophagy, mitophagy, and apoptosis genes in the CA3 region of the hippocampus in the ischemic model of Alzheimer’s disease in the rat. J Alzheimer’s Dis 72:1279–1286
Martín-Maestro P, Gargini R, Perry G, Avila J, García-Escudero V (2016) PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer’s disease. Hum Mol Genet 25:792–806
Cheng Y, Bai F (2018) The association of tau with mitochondrial dysfunction in Alzheimer’s disease. Front Neurosci 12:163
Abtahi SL, Masoudi R, Haddadi M (2020) The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster. Gene 754:144854
Manczak M, Kandimalla R, Yin X, Reddy PH (2018) Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer’s disease. Hum Mol Genet 27:1332–1342
Li Y, Liu Q, Sun J et al (2018) Mitochondrial protective mechanism of simvastatin protects against amyloid β peptide-induced injury in SH-SY5Y cells. Int J Mol Med 41:2997–3005
Swerdlow RH (2018) Mitochondria and mitochondrial cascades in Alzheimer’s disease. J Alzheimer’s Dis 62:1403–1416
Du H, Guo L, Fang F, Chen D, Medicine AS (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nature Med 14:1097–1105
Birnbaum JH, Wanner D, Gietl AF, Saake A, Kündig TM, Hock C et al (2018) Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer’s disease patients. Stem Cell Res 27:121–130
Physiology C, Ferrer MD, Sureda A, Mestre A, Tur JA, Pons A et al (2010) Cellular physiology cellular physiology cellular physiology cellular physiology the double edge of reactive oxygen species as damaging and signaling molecules in HL60 cell culture. Cell PhysiolBiochem 25:241–252
Reddy P, Tripathi R, Troung Q et al (2012) Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: implications to mitochondria-targeted antioxidant. Biochim Biophys basis Dis 1822:639–649
Du F, Yu Q, Yan S et al (2017) PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease. Brain 140:3233–3251
Blanco-Bose Amazentis W, Ryu D, Burdet F (2019) The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabol 1:595–603
Lee J, Kim Y, Liu T, et al (2018) SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer’s disease. Aging Cell 17:e12679
Geng X, Yang B, Li R et al (2020) Effects of docosahexaenoic acid and its peroxidation product on amyloid-β peptide-stimulated microglia. Mol Neurobiol 57:1085–1098
Shoshan-Barmatz V (2018) Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction. Google Patents 2018.
Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A (2017) Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther 23:5–22
Yang L, Jiang Y, Shi L et al (2020) AMPK: potential therapeutic target for Alzheimer’s disease. Curr protein Pept Sci 21:66–77
Chiang M, Cheng Y, Chen S et al (2016) Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction. Exp Cell Res 347:322–331
Kanthasamy A, B Kalyanaraman - US Patent 9, 956 233, 2018 U (2018) Neuroprotection by mitochondria-targeted metformin. Google Patents
Kanthasamy A, B Kalyanaraman - US Patent 10, 576 093, 2020 U (2020) Neuroprotection by mitochondria-targeted metformin. Google Patents
Kim DI, Lee KH, Gabr AA, etal (2016) Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863:2820–2834
Qi X, Qvit N, Su Y-C, Mochly-Rosen D (2013) A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci 126:789–802
Cenini G, Voos W (2019) Mitochondria as potential targets in Alzheimer disease therapy: An update. Front Pharmacol 10:902
Xu Y, Mei Y, Shi X et al (2019) Albiflorin ameliorates memory deficits in APP/PS1 transgenic mice via ameliorating mitochondrial dysfunction. Brain Res 1719:113–123
Oliver D (2019) Small molecules as therapeutic drugs for Alzheimer’s disease. Mol Cell Neurosci 96:47–62
Kisby B, Jarrell J, Agar M et al (2019) Alzheimer’s disease and its potential alternative therapeutics. J Alzheimers Dis Parkinsonism 9:477
Magadmi RM, Alsulaimani MA, Al-Rafiah AR, Ahmad MS, Esmat A (2021) Carvedilol exerts neuroprotective effect on rat model of diabetic neuropathy. Front Pharmacol 12:613–634
Liu J, Wang M (2018) Carvedilol protection against endogenous Aβ-induced neurotoxicity in N2a cells. Cell Stress Chaperones 23:695–702
Wang CY, Xu Y, Wang X et al (2019) Dl-3-n-Butylphthalide inhibits NLRP3 inflammasome and mitigates Alzheimer’s-like pathology via Nrf2-TXNIP-TrX Axis. Antioxidants Redox Signal 30:1411–1431
Liu Z, Wang H, Xiaofeng S, Liwen L, Zhou M, Hui D, et al (2017) dl-3-n-Butylphthalide (NBP) Provides neuroprotection in the mice models after traumatic brain injury via Nrf2-ARE signaling pathway. Neurochem Res 42:1375–86
Luo R, Wangqin R, Zhu L, Bi W (2019) Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases. Biomed Reports 11:235–240
Vasilieva NA, Shevtsova EF, Van’kin GI, et al (2019) Wave-like dose-dependence of the stimulating effects of dimebon on cognition in a wide dose range. Bull Exp Biol Med 167:740–743
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO et al (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study. The Lancet 372:207–215
Eckert SH, Gaca J, Kolesova N, Friedland K, Eckert GP, Muller WE (2018) Mitochondrial pharmacology of dimebon (latrepirdine) calls for a new look at its possible therapeutic potential in alzheimer’s disease. Aging Dis 9:729–744
Zhang T, Wu P, Zhang JH, Li Y, Xu S, Wang C et al (2018) Docosahexaenoic acid alleviates oxidative stress-based apoptosis via improving mitochondrial dynamics in early brain injury after subarachnoid hemorrhage. Cell Mol Neurobiol 38:1413–1423
Farr S, Roesler E, Neihoff ML et al (2019) Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. Journal of Alzheimer’s disease 68:1699–1710
Docrat TF, Nagiah S, Naicker N, Baijnath S, Singh S, Chuturgoon AA (2020) The protective effect of metformin on mitochondrial dysfunction and endoplasmic reticulum stress in diabetic mice brain. Eur J Pharmacol 875:173059
Izzo A, Nitti M, Mollo N, Paladino S, Procaccini C, Faicchia D et al (2017) Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells. Hum Mol Genet 26:1056–1069
Lawlor B, Segurado R, Kennelly S, et al (2018) Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med 15:e1002660
Singh SK, Srivastav S, Castellani RJ et al (2019) Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 16:666–674
Chen L, Zhang C, Han Y, Meng X, Zhang Y, Chu H, et al (2019) Gingko biloba Extract (EGb) inhibits oxidative stress in neuro 2A cells overexpressing APPsw. Biomed Res Int 2019
Chen W-P, Cheng Z-J, Zhang G, Luo Q-H, Li M, Tu J-L, et al (2020) EGb761 ameliorates cell necroptosis by attenuating RIP1-mediated mitochon-drial dysfunction and ROS production in both in vivo and in vitro models of Alzheimer’s disease. Brain Res 1736:146730
Khalatbary AR, Khademi E (2020) The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection. Nutr Neurosci 23:281–294
Qin S, Chen MH, Fang W, Tan XF, Xie L, Yang YG et al (2019) Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model. Drug Des Devel Ther 13:2759–2768
Mi Y, Qi G, Gao Y, Li R, Wang Y, Li X et al (2017) (-)-Epigallocatechin-3-gallate ameliorates insulin resistance and mitochondrial dysfunction in HepG2 cells: involvement of Bmal1. Mol Nutr Food Res 61:1700440
Grimm MOW, Mett J, Stahlmann CP et al (2016) Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme1. Biochem Cell Biol 94:534–542
Quitterer U, Research SA-P, 2020 U (2020) Improvements of symptoms of Alzheimers disease by inhibition of the angiotensin system. Pharmacol Res 154:104230
Márquez-Ramírez CA, Hernández de la Paz JL, Ortiz-Avila O, Raya-Farias A, González-Hernández JC, Rodríguez-Orozco AR et al (2018) Comparative effects of avocado oil and losartan on blood pressure, renal vascular function, and mitochondrial oxidative stress in hypertensive rats. Nutrition 54:60–67
Alawdi S, Eidi H, … MS-N, 2019 U (2019) Loading amlodipine on diamond nanoparticles: a novel drug delivery system. Nanotechnol Sci Appl 12:47–53
Nili-Ahmadabadi A, Ali-Heidar F, Ranjbar A, Mousavi L, Ahmadimoghaddam D, Larki-Harchegani A et al (2018) Protective effect of amlodipine on diazinon-induced changes on oxidative/antioxidant balance in rat hippocampus. Res Pharm Sci 13:368–376
Khatoon R, Sciences SP-J of the N, 2019 U (2019) Pramipexole improves mitochondrial function in aβ42 induced transgenic ad model of drosophila melanogaster. J Neurol Sci 405
Andrabi SS, Ali M, Tabassum H, Parveen S, Parvez S (2019) Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke. DMM Dis Model Mech 12:dmm033860
Voulgaropoulou S, Amelsvoort T van, Research JP-B, 2019 U (2019) The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res 1725:146476
Farkhondeh T, Samarghandian S, Pourbagher-Shahri AM, Sedaghat M (2019) The impact of curcumin and its modified formulations on Alzheimer’s disease. J Cell Physiol 234:16953–16965
Tsai M, Lin S, Hidayah K et al (2019) Equol pretreatment protection of SH-SY5Y cells against Aβ (25–35)-induced cytotoxicity and cell-cycle reentry via sustaining estrogen receptor alpha expression. Nutrients 11:2356
Lanzillotta C, Di Domenico F, Perluigi M, Butterfield DA (2019) Targeting mitochondria in Alzheimer disease: rationale and perspectives. CNS Drugs 33:957–969
Eser Faki H, Tras B, Uney K (2020) Alpha lipoic acid and vitamin E improve atorvastatin-induced mitochondrial dysfunctions in rats. Mitochondrion 52:83–88
Zhao H, Zhao X, Liu L, Zhang H, Xuan M, Guo Z et al (2017) Neurochemical effects of the R form of α-lipoic acid and its neuroprotective mechanism in cellular models of Parkinson’s disease. Int J Biochem Cell Biol 87:86–94
Young M (2019) The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice. Mol Cell Neurosci 101:103409
Xi Y, Feng D, Tao K, Wang R, Shi Y, Qin H et al (2018) MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α. Biochim Biophys Acta - Mol Basis Dis 1864:2859–2870
Polyak E, Ostrovsky J, Peng M, Dingley SD, Tsukikawa M, Kwon YJ et al (2018) N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease. Mol Genet Metab 123:449–462
Hinnoutondji Toffa D, Annick Magnerou M, Kassab A et al (2019) Can magnesium reduce central neurodegeneration in Alzheimer’s disease? Basic evidences and research needs. Neurochem Int 126:195–202
Mohammadi H, Shamshirian A, Eslami S, Shamshirian D, Ebrahimzadeh MA (2020) Magnesium Sulfate Attenuates Lethality and Oxidative Damage Induced by Different Models of Hypoxia in Mice. Biomed Res Int 2020
Soares R et al (2018) Tauroursodeoxycholic acid enhances mitochondrial biogenesis, neural stem cell pool, and early neurogenesis in adult rats. Mol Neurobiol 55:3725–3738
Acknowledgements
Not applicable
Author information
Authors and Affiliations
Contributions
Rishika Dhapola wrote the manuscript, Phulen Sarma wrote the manuscript, Bikash Medhi design and edited manuscript, Ajay Prakash edited manuscript, and Dibbanti HariKrishna Reddy designed, wrote, and edited manuscript.
Corresponding author
Ethics declarations
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dhapola, R., Sarma, P., Medhi, B. et al. Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease. Mol Neurobiol 59, 535–555 (2022). https://doi.org/10.1007/s12035-021-02612-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-021-02612-6